← Back to patent-cliff list
无水乙醇注射液（Eton Pharmaceuticals）
Tier C — Watch / tradeDehydrated Alcohol Injection (Eton Pharmaceuticals)
Eton Pharmaceuticals Inc
Originator
2018
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Not applicable
Indications (approved)：甲醇中毒、肥大型心肌病
Regional status
US
批准上市
2018-06-21
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Dehydrated Alcohol Injection (Eton Pharmaceuticals)?
Approved indications include: 甲醇中毒, 肥大型心肌病.
When does the Dehydrated Alcohol Injection (Eton Pharmaceuticals) patent expire?
No public expiry year is available for Dehydrated Alcohol Injection (Eton Pharmaceuticals) yet; this page updates once verified.
How do I get a quote for Dehydrated Alcohol Injection (Eton Pharmaceuticals) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24